ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A novel prognostic model: which group of esophageal squamous cell carcinoma patients could benefit from adjuvant chemotherapy

Zhou, Zihao; Huang, Shujie; Ben, Xiaosong; Zhuang, Weitao; Hong, Liangli; Xie, Zefeng; Zhang, Dongkun; Xie, Liang; Zhou, Haiyu; Tang, Jiming; Chen, Gang; Wu, Hansheng*; Qiao, Guibin*广东省人民医院; 南方医科大学; 汕头大学; 1
Annals of Translational Medicine2022-2DOI: 10.21037/atm-22-46
1被引7阅读
引用收藏
分享

摘要

Background: This study aimed to establish a reliable model for predicting the overall survival (OS) of esophageal squamous cell carcinoma (ESCC) patients and identifying the potential beneficiaries of adjuvant chemotherapy after esophagectomy. Methods: This retrospective study included 819 ESCC patients who underwent esophagectomy as the training cohort. We constructed a prognostic model named GTLN2. Both internal and external validation tests were performed. Potential beneficiaries were defined as ESCC patients who obtained a significantly longer OS after adjuvant chemotherapy. Propensity score matching (PSM) was utilized in the subgroup analysis to screen ESCC beneficiaries of adjuvant chemotherapy. Results: We enrolled a total of 819 cT1b-3 patients in the training cohort. Multiple prognostic factors were associated with adjuvant chemotherapy. Using uni-/multivariate analysis, histological grade (G), tumor invasion depth (T), regional lymph node metastasis (N), and the number of cleared lymph nodes (NCLNs) were identified as independent prognostic factors. Then, we developed the GTLN2 model based on these predictors and validated it using internal calculations [the 1-, 3-and 5-year area under the curves (AUCs) were 0.692, 0.685 and 0.680, respectively; P<0.001] and external cohorts (the 1-, 3-, and 5-year AUCs were 0.651, 0.619 and 0.650, respectively; P<0.001). ESCC patients were categorized into high-and low-risk groups based on their assigned risk scores. After 1:1 patient pairing was performed by PSM in the high-risk group, better OS was noted in patients receiving adjuvant chemotherapy (P=0.024). Conclusions: Differentiating high-and low-risk patient groups via a novel mathematical prediction model allows physicians to identify patients in need of adjuvant chemotherapy accurately.

学科与关键词

关键词
Esophageal squamous cell carcinoma (ESCC)adjuvant chemotherapyprognostic modeloverall survival (OS)real-world study
相关
加载中…
  • Prognostic significance of tumor regression grade in esophageal squamous cell carcinoma after neoadjuvant chemoradiation
    Zhang, Chi; Xu, Fei; Qiang, Yong; Cong, Zhuang-Zhuang; Wang, Qin; Zhang, Zheng; Luo, Chao; Qiu, Bing-Mei*; Hu, Li-Wen*; Shen, Yi*Frontiers in Surgery, 2023, 9: 1029575.被引 1
  • Distinguishing optimal esophagectomy candidates in elderly patients: A nomogram based on propensity score matching
    Zheng, Chao; Luo, Chao; Xie, Kai; Qiang, Yong; Wang, Gao-Ming*; Shen, Yi*EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2022, 48(4): 909-916.被引 2
  • Tumor Compactness based on CT to predict prognosis after multimodal treatment for esophageal squamous cell carcinoma
    Wang, Qifeng; Cao, Bangrong; Chen, Junqiang; Li, Chen; Tan, Lijun; Zhang, Wencheng; Lv, Jiahua; Li, Xiqing; Xiao, Miyong; Lin, Yu; Lang, Jinyi; Li, Tao*; Xiao, Zefen*SCIENTIFIC REPORTS, 2019, 9: 10497.
查看全部 →

发表信息

论文状态
公开发表
期刊
Annals of Translational Medicine
发表日期
2022-02
卷期
第 10 卷, 第 4 期
DOI
10.21037/atm-22-46
期刊等级
4区
成果收录
SCIE
资助标注
2020-2021 Popularization of Science and Technology Innovation Special Project of Guangdong Province of China [2020A1414070007]; Science and Technology Program of Guangzhou, China [201704020107]

作者

  • Z

    Zhou, Zihao (第一作者)

    guangdong prov peoples hosp

  • H

    Huang, Shujie

    guangdong prov peoples hosp · shantou univ

查看全部 13 位作者收起作者
  • B

    Ben, Xiaosong

    guangdong prov peoples hosp

  • Z

    Zhuang, Weitao

    guangdong prov peoples hosp · shantou univ

  • H

    Hong, Liangli

    1 · shantou univ

  • X

    Xie, Zefeng

    1 · shantou univ

  • Z

    Zhang, Dongkun

    guangdong prov peoples hosp

  • X

    Xie, Liang

    guangdong prov peoples hosp

  • Z

    Zhou, Haiyu

    guangdong prov peoples hosp

  • T

    Tang, Jiming

    guangdong prov peoples hosp

  • C

    Chen, Gang

    guangdong prov peoples hosp

  • W

    Wu, Hansheng (通讯)

    1 · shantou univ · guangdong prov peoples hosp

  • Q

    Qiao, Guibin (通讯)

    guangdong prov peoples hosp · 2 · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417